Clinical Trials Logo

Clinical Trial Summary

This is a randomized, double-blind, within-subjects, cross-over design to assess neural changes following a single dose of cannabidiol (CBD) (600mg) versus placebo among healthy female volunteers.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04777643
Study type Interventional
Source Yale University
Contact
Status Completed
Phase Early Phase 1
Start date June 7, 2022
Completion date April 27, 2023

See also
  Status Clinical Trial Phase
Completed NCT04976738 - A Study of Cybis™ 10:25 THC:CBD Oil in Adults With Chronic Back/Neck Pain Phase 1/Phase 2
Not yet recruiting NCT04729244 - The Study of Hemp Oil CBD for Evaluation of Efficacy and Safety in Treatment of Pain, Anxiety and Insomnia Management Phase 1
Recruiting NCT05490511 - Drug-gene-nutraceutical Interactions of Cannabidiol and Tacrolimus Phase 1
Withdrawn NCT04412837 - The Use of Cannabinoid Patch for Knee Osteoarthritis Phase 2
Completed NCT05121506 - A Study to Investigate the Bioavailability and Skin Absorption of CBD and THC From GT4 Technology in Healthy Adults Phase 1
Completed NCT04360044 - Efficacy of Inhaled Cannabis for Acute Migraine Treatment Phase 2
Recruiting NCT04611347 - Topical CBD in Joint Arthritis Phase 2
Enrolling by invitation NCT04680130 - Clinico-Pathologic-Genetic-Imaging Study of Neurodegenerative and Related Disorders
Recruiting NCT04398719 - CBD-Microglia PET Study Early Phase 1
Completed NCT04423341 - Effect of Non-psychoactive Cannabidiol as an Adjunct to Botulinum Toxin in Blepharospasm Phase 2/Phase 3
Active, not recruiting NCT04997954 - EMERALD TRIAL Open Label Extension Study Phase 4
Recruiting NCT04030442 - Cannabidiol, Morphine, Pain Phase 1
Completed NCT04851392 - Do Adolescents and Adults Differ in Their Acute Response to Cannabis? N/A
Recruiting NCT05956834 - A Multi-Modal Remote Monitoring Platform for Frontotemporal Lobar Degeneration (FTLD) Syndromes
Recruiting NCT05562635 - CBD (Cannabidiol) Intraoral Application and TMD (Temporomandibular Disorders) Phase 2/Phase 3
Active, not recruiting NCT04831294 - Effects of Cannabidiol (CBD) on the Brain N/A
Recruiting NCT04686539 - Synthetic CBD as a Therapy for COVID-19 Phase 1
Active, not recruiting NCT04482244 - RCT of CBD for Anxiety in Advanced Breast Cancer Phase 2
Recruiting NCT04775030 - Methodology for Developing an Occlusal Appliance With CBD Active Carrier Phase 2/Phase 3
Recruiting NCT04527003 - Cannabidiol and Management of Endometriosis Pain Phase 3